Sign Up to like & get
recommendations!
0
Published in 2017 at "Reproductive biomedicine online"
DOI: 10.1016/j.rbmo.2016.10.004
Abstract: Triptorelin 0.2 mg and leuprolide 1 mg subcutaneous injections for triggering final follicular maturation were compared in patients with a high risk for ovarian hyperstimulation syndrome (OHSS). Infertile patients treated with GnRH antagonist protocol between January 2014…
read more here.
Keywords:
ovarian hyperstimulation;
final oocyte;
risk;
risk ovarian ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Reproductive biomedicine online"
DOI: 10.1016/j.rbmo.2017.09.002
Abstract: Previous studies show that a dual trigger ovulation regimen significantly improves number and maturity of retrieved oocytes for normal ovarian responders or patients with history of low oocyte yield. The current retrospective cohort study investigated…
read more here.
Keywords:
final oocyte;
ovarian responders;
dual trigger;
rate ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2018.00033
Abstract: Ovarian stimulation in a gonadotropin-releasing hormone (GnRH) antagonist protocol with the use of GnRH agonist for final oocyte maturation is the state-of-the-art treatment in patients with an expected or known high response to avoid or…
read more here.
Keywords:
releasing hormone;
final oocyte;
gonadotropin releasing;
oocyte maturation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.831859
Abstract: Introduction The choice of trigger drug for the controlled ovarian hyperstimulation (COH) protocol correlates with the outcome of in vitro fertilization/intracytoplasmic sperm injection embryo transfer (IVF/ICSI-ET). The co-administration of gonadotropin releasing hormone agonist (GnRH-a) and…
read more here.
Keywords:
dual trigger;
hcg;
final oocyte;
rate ... See more keywords